Percutaneous transhepatic choledochoscopic injection of ethanol with OK-432 mixture for palliation of malignant biliary obstruction

Gastrointestinal Endoscopy

Volumn 57, Issue 5, 2003, Pages 769-773

  Park, Seung Woo ^a   Lee, Don Haeng ^b   Park, Young Soo ^b   Chung, Jae Bock ^b   Kang, Jin Kyung ^b   Song, Si Young ^b  

^a Yonsei University College of Medicine   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; PICIBANIL;

ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; BILIARY TRACT ENDOSCOPY; CANCER PALLIATIVE THERAPY; CASE REPORT; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FOLLOW UP; HUMAN; INTRAHEPATIC BILE DUCT; MALE; PRIORITY JOURNAL; SAFETY; STENT; TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; BILE DUCT CARCINOMA; BIOPSY; CLINICAL FEATURE; DUODENOSCOPY; FEVER; HUMAN TISSUE; JAUNDICE; SURGICAL TECHNIQUE;

EID: 1142311483     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2003.218     Document Type: Article

References (24)

1. Suzuki K, Tsuge I, Ito Y, Kunii H, Baba S. Histological effect of intranodal injection of the streptococcal preparation OK-432 for cervical lymph node metastases of malignant head and neck tumors. Acta Otolaryngol 1996;525:125-8.
2. Fujimoto T, Duda RB, Szilvasi A, Chen X, Mai M, O'Donnell MA. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state. J Immunol 1997;158:5619-36.
3. Smith RJH, Burke DK, Sato Y, Poust RI, Kimura K, Bauman NM. OK-432 therapy for lymphangiomas. Arch Otolaryngol 1996;122:1195-9.
4. Suzuki Y, Obana A, Gohto Y, Miki T, Otuka H, Inoue Y. Management of orbital lymphangioma using intralesional injection of OK-432. Br J Ophthalmol 2000;84:614-7.
5. Sakita I, Monden T, Nagaoka H, Katsumoto Y, Wakasugi T, Tomita N, et al. Augmentation of antitumor immunity in regional lymph nodes by local immunotherapy. Biotherapy 1993;6:103-12.
6. Kitahara S, Ikeda M, Inouye T, Matsunaga T, Yamaguchi K, Takayama E, et al. Inhibition of head and neck metastatic and/or recurrent cancer by local administration of multicytokine inducer OK-432. J Laryngol Otol 1996;110:449-53.
7. Katano M, Morisaki T. The past, the present and future of the OK-432 therapy for patients with malignant effusions. Anticancer Res 1998;18:3917-26.
8. Hihara J, Yamaguchi Y, Minami K, Noma K, Toge T. Down-regulation of IL-10 enhances the efficacy of locoregional immunotherapy using OK-432 against malignant effusion. Anticancer Res 1999;19:1077-84.
9. Inui S, Asada H, Yoshikawa K. Successful treatment of molluscum contagiosum in the immunosuppressed adult with topical injection of streptococcal preparation OK-432. J Dermatol 1996;23:628-30.
10. Okamoto T, Harada M, Tamada K, Yoshida H, Ito O, Kong YY, et al. Local injection of OK-432 can augment the Th1-type T-cell response in tumor-draining lymph node cells and increase their immunotherapeutical potential. Int J Cancer 1997;70:598-605.
11. Yamagiwa S, Ichida T, Sato K, Sugahara S, Yonekura K, Uchida M, et al. Liposome-encapsulated OK-432 specifically and sustainedly induced hepatic natural killer cells and intermediated T cell receptor cells. J Gastroenterol Hepatol 2000;15:542-9.
12. Okamoto M, Gohda H, Ohe G, Yoshida H, Matsuno T, Saito M, et al. Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-7-inducing molecule derived from OK-432, a streptococcal preparation. J Immunother 2000;23:94-103.
13. Takahashi K, Harauchi D, Kimura S, Saito S, Monden Y. OK-432 develops CTL and LAK activity in mononuclear cells from regional lymph nodes of lung cancer patients. Int J Immunopharmacol 1998;20:375-88.
14. Ogawa K, Konno SI, Takebayashi Y, Murayama M, Shimakawa T, Katsube T, et al. Effect of intratumoral OK-432 administration on thymidine phosphorylase expression in human gastric carcinoma. Anticancer Res 2001;21:1257-62.
15. Horigome H, Nomur T, Saso K, Itoh M. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence. Am J Gastroenterol 1999;94:1914-7.
16. Yamamoto H, Hayakawa N, Nagino M, Kamiya J, Nimura Y. Percutaneous transhepatic cholangioscopic ethanol injection for intrabiliary tumor thrombi due to hepatocellular carcinoma. Endoscopy 1999;31:204-6.
17. Carazzone A, Bonavina L, Segalin A, Ceriani C, Peracchia A. Endoscopic palliation of oesophageal cancer: result of a prospective comparison of Nd:YAG laser and ethanol injection. Eur J Surg 1999;165:351-6.
18. Chan MK, Kwok PC, Chan SC, Lam TW, Lo KK, Lam CL. Percutaneous ethanol injection as a possible curative treatment for malignant portal vein thrombosis in hepatocellular carcinoma. Cardiovasc Inter Radiol 1999;22:326-8.
19. Nakayama J, Kokuba H, Kobayashi J, Yoshida Y, Hori Y. Experimental approaches for the treatment of murine B16 melanomas of various sizes. I: Local injection of ethanol with a combination of interleukin-2 or microwaval hyperthermia for B16 melanomas with a size of less than 7 mm in diameter. J Dermatol Sci 1997;15:75-81.
20. Ichimura O, Suzuki S, Saito M. Augmentation of interleukin 1 and interleukin 2 production by OK-432. Int J Immunopharmacol 1985;7:262-8.
21. Fukui H, Koishihara Y, Nagamuta M, Mizutani Y, Uchida A. Production of interleukin 6 by human spleen cells stimulated with streptococcal preparation OK-432. Immunol Lett 1989; 21:127-30.
22. Saito M, Ebina T, Koi M, Yamaguchi T, Kamade Y, Ishida N. Induction of interferon-7 in mouse spleen cell by OK-432, a preparation of streptococcus pyogenes. Cell Immunol 1982; 68:187-92.
23. Yamamoto A, Nagamuta M, Usami H, Sugawara Y Watanabe N, Niitsu Y, et al. Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation. Immunopharmacology 1986;11:79-86.
24. Oshimi K, Kano S, Takaku F, Okumura K. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432. J Natl Cancer Inst 1980;65:1265-9.